Abstract
Treatment in vitro of human peripheral blood lymphocytes (PBL) with ConA induced the generation of suppressor cells which inhibited T cell blastogenic response to ConA and of allogeneic response in the mixed lymphocyte reaction (MLR). Treatment of PBL with 4-hydroperoxycyclophosphamide (4-HPCy) before incubation with ConA markedly decreased the generation of suppressor cells by ConA. The effect of 4-HPCy on generation of suppressor cells was more pronounced in the test of ConA stimulation than in the MLR. Treatment with 4-HPCy had no effect on suppressor cells already induced as shown by incubation of PBL with 4-HPCy after incubation with ConA.
Keywords: Cancer Research, Blood Lymphocyte, Peripheral Blood Lymphocyte, Human Peripheral Blood, Concanavalin
References
- 1.Askenase PW, Haysten BJ, Gershon RK. Augmentation of delayed type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses. J Exp Med. 1975;141:697. doi: 10.1084/jem.141.3.697. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Berd D, Danna V, Maguire H, Mastrangelo M. Selective impairment of suppressor T cell function after administration of cyclophosphamide. Proc Am Assoc Cancer Res. 1982;23:279. [Google Scholar]
- 3.Boyum A. Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest Suppl. 1968;21:97. [PubMed] [Google Scholar]
- 4.Diamantstein T, Klos M, Hahn H, Kaufmann SHE. Direct in vitro evidence for different susceptibilities to 4-hydroperoxycyclophosphamide of antigen-primed T cells regulating humoral and cell mediated immune responses to sheep erythrocytes. J Immunol. 1981;126:1717. [PubMed] [Google Scholar]
- 5.Gill HK, Liew FY. Regulation of delayed type hypersensitivity. Eur J Immunol. 1978;8:172. doi: 10.1002/eji.1830080306. [DOI] [PubMed] [Google Scholar]
- 6.Hallgren HM, Yunis EJ. Suppressor lymphocytes in young and aged humans. J Immunol. 1977;118:2004. [PubMed] [Google Scholar]
- 7.Kaufmann SHE, Hahn H, Diamanstein T. Relative susceptibility of T cell subsets involved in delayed-type hypersensitivity to sheep red blood cells to the in vitro action of 4-hydroperoxycyclophosphamide. J Immunol. 1980;125:1104. [PubMed] [Google Scholar]
- 8.L'Age-Stehr J, Diamanstein T. Induction of autoreactive T lymphocytes and their suppressor cells by cyclophosphamide. Nature. 1978;271:663. doi: 10.1038/271663a0. [DOI] [PubMed] [Google Scholar]
- 9.Maguire H, Berd D, Engstrom P, Manstrangelo M. Cyclophosphamide increases the acquisition of T cell immunity in patients with melanoma and colo-rectal cancer. Proc Am Assoc Cancer Res. 1981;22:279. [Google Scholar]
- 10.Ozer HJ, Cowens W, Colvin M, Blumenson A, Sheedy D. In vitro effect of 4-hydroperoxycyclophosphamide on human immunoregulatory T subset function. J Exp Med. 1982;155:276. doi: 10.1084/jem.155.1.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Shand FL. Review/Commentary. The immunopharmacology of cyclophosphamide. J Immunopharmacol. 1979;1:165. doi: 10.1016/0192-0561(79)90038-9. [DOI] [PubMed] [Google Scholar]
- 12.Shand FL, Howard JG. Induction in vitro of reversible immunosuppression and inhibition of B cell receptor regeneration by defined metabolites of cyclophosphamide. Eur J Immunol. 1979;9:17. doi: 10.1002/eji.1830090105. [DOI] [PubMed] [Google Scholar]
- 13.Shou L, Schwartz SA, Good RA. Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors. J Exp Med. 1976;143:1100. doi: 10.1084/jem.143.5.1100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Winer BJ. In: Statistical principles in experimental design. 2nd edn. Winer BJ, editor. London New York: McGraw-Hill; 1971. [Google Scholar]